Fertility drugs don't raise risk of uterine cancer recurrence

12/26/2012 | PhysiciansBriefing.com

Women who took fertility drugs after fertility-sparing therapy for uterine cancer were not more likely to experience recurrence than those who didn't receive fertility drugs, according to a review in the journal Obstetrics & Gynecology. Researchers looked at data on 141 patients and found a similar rate of five-year disease-free survival among women who did and didn't take fertility treatments.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD